Bionexus Gene Lab Corp. (BGLC)
NASDAQ · Basic Materials
Bionexus Gene Lab Corp. Operating Income 2018–2025
Bionexus Gene Lab Corp. annual/quarterly operating income history and growth rate from 2018 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Bionexus Gene Lab Corp. operating income for the quarter ending March 31, 2026 was -540490, a 12.60% decrease year-over-year.
- Bionexus Gene Lab Corp. operating income for the twelve months ending March 31, 2026 was -2.5 M, a 32.92% decrease year-over-year.
- Bionexus Gene Lab Corp. annual operating income for 2025 was -3.0 M, a 88.41% increase from 2024.
- Bionexus Gene Lab Corp. annual operating income for 2024 was -1.6 M, a 39.32% decrease from 2023.
- Bionexus Gene Lab Corp. annual operating income for 2023 was -2.6 M, a 790.73% increase from 2022.
- Bionexus Gene Lab Corp. annual operating income for 2022 was -291177.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Bionexus Gene Lab Corp. Operating Income — FAQ
Bionexus Gene Lab Corp. (BGLC) operating income over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
What is Bionexus Gene Lab Corp.'s operating income?
Bionexus Gene Lab Corp. (BGLC) reported operating income of -$3M for fiscal 2025.
Where can I see BGLC's operating income history?
The chart and table above show Bionexus Gene Lab Corp.'s operating income by year and by quarter, including the growth rate.